The September 2012 issue of Clinical Chemistry (out now!) features a Q&A with several experts on the difficulty to diagnose ectopic pregnancy. Diagnosing ectopic pregnancy has been a challenge to many in the laboratory as it has a difficult etiology to study and rarely occurs in animal models. A reliable biomarker for ectopic preganacy would effectively change the game, but of the several biomarkers that have been identified in serum, few have been successfully implemented. One provocative question presented to the panel regarded the financial implications of the lack of a reliable biomarker. For today's Daily Discussion, we want you to tell us: Is the difficulty in diagnosing ectopic pregnancy adding substantial financial burden to the healthcare system, and would a new biomarker improve this?